Sponsor:
Duke University
Code:
NCT07232069
Conditions
Coronary Artery Disease Risk Factors Multiple
Coronary Artery Disease Progression
Prevention & Control
Premature Atherosclerosis
Eligibility Criteria
Sex: All
Age: 30 - 60
Healthy Volunteers: Not accepted
Interventions
Rosuvastatin 20 Mg Oral Tablet
Colchicine 0.5 MG Oral Tablet Once Daily
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-12. This information was provided to ClinicalTrials.gov by Duke University on 2026-08-11.